Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation ...

Nutcracker Therapeutics and Elegen see their mission as delivering scalable and low-cost RNA manufacturing for individualized therapies.

The mRNA therapeutics field is rapidly evolving beyond vaccines to include treatments for cancer, genetic disorders and in vivo cell therapies, bringing with it diverse production challenges. As the ...

Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

Monkeypox Vaccine and Treatment revenue is expected to grow at a CAGR of 10.20% from 2025 to 2032, reaching nearly USD 225.12 Mn by 2032.

Test your knowledge on the significance of pairing artificial intelligence with unified namespace. Dan Malyszko wrote in this article how important it is to use artificial intelligence and unified ...

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies, has transferred the upstream phase of the manufacturing process for LUMEVOQ, its gene ...

The Cobra platform replaces the company’s Raptor process, which was used for B0 cell production and delivered important gains in separator quality and process stability.

Smart mRNA drugs listen to the body, adjusting protein production based on disease-related signals by University of Osaka ...